Aristo Pharma Nordic ApS: Financial statements 2014
CVR: 32328768
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Aristo Pharma Nordic ApS (CVR 32328768) has filed annual accounts for 2014. In 2014, the company reported a gross profit of EUR -733,672 and a net result of EUR -1,668,647. Equity in the 2014 report amounted to EUR -1,059,258. The company had 12 employees in the financial year.
- Gross Profit
- EUR -733,672
- Profit/Loss
- EUR -1,668,647
- Equity
- EUR -1,059,258
- Total Assets
- EUR 3,436,986
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -734 t. EUR | -1.7 mio. EUR | -1.1 mio. EUR | 12 |
| 2012 | - | -297 t. | -428 t. | -484 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of December 30, 2014, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Aristo Pharma Nordic ApS.
As of December 30, 2014, EY Danmark A/S has stepped down as auditor of Aristo Pharma Nordic ApS.
On May 12, 2014, the company changed its name from COPHARMA ApS to AMNEAL NORDIC ApS.
Aristo Pharma Nordic ApS has published its interim report for the period October 1, 2012 to December 31, 2013.
As of April 14, 2014, EY Danmark A/S has been appointed auditor of Aristo Pharma Nordic ApS.
As of April 14, 2014, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Aristo Pharma Nordic ApS.
As of April 14, 2014, János Váczi has joined the board of directors of Aristo Pharma Nordic ApS.
As of April 14, 2014, Joseph Todisco has joined the board of directors of Aristo Pharma Nordic ApS.
As of April 14, 2014, Peter Prock has joined the board of directors of Aristo Pharma Nordic ApS.
About Aristo Pharma Nordic ApS
Aristo Pharma Nordic ApS is a Danish company of the type Anpartsselskab based in Skovlunde, founded in 2011. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named AMNEAL NORDIC ApS and COPHARMA ApS. The management consists of John Hudson Kriwet. The board consists of John Hudson Kriwet (chair), Jannes Paul Beeskow and Robert Maciej Szymanski. The company is owned by Aristo Pharma GmbH. The company has 1 employee (2026). In 2025, the company reported revenue of EUR 453,392 and a net result of EUR 21,589 compared with EUR 25,190 the year before. Equity in the 2025 report amounted to EUR 184,874.